S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
New CBOE “special perk” helps traders target income every weekend (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
New CBOE “special perk” helps traders target income every weekend (Ad)
What is carbon capture and why does it keep coming up at COP28?
Dozens of animals taken from Virginia roadside zoo as part of investigation
New CBOE “special perk” helps traders target income every weekend (Ad)
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
Peek inside Joe Biden's campaign fundraisers, where big money mingles with old jokes in swanky homes
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
New CBOE “special perk” helps traders target income every weekend (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
New CBOE “special perk” helps traders target income every weekend (Ad)
What is carbon capture and why does it keep coming up at COP28?
Dozens of animals taken from Virginia roadside zoo as part of investigation
New CBOE “special perk” helps traders target income every weekend (Ad)
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
Peek inside Joe Biden's campaign fundraisers, where big money mingles with old jokes in swanky homes
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
New CBOE “special perk” helps traders target income every weekend (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
New CBOE “special perk” helps traders target income every weekend (Ad)
What is carbon capture and why does it keep coming up at COP28?
Dozens of animals taken from Virginia roadside zoo as part of investigation
New CBOE “special perk” helps traders target income every weekend (Ad)
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
Peek inside Joe Biden's campaign fundraisers, where big money mingles with old jokes in swanky homes
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
New CBOE “special perk” helps traders target income every weekend (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
New CBOE “special perk” helps traders target income every weekend (Ad)
What is carbon capture and why does it keep coming up at COP28?
Dozens of animals taken from Virginia roadside zoo as part of investigation
New CBOE “special perk” helps traders target income every weekend (Ad)
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
Peek inside Joe Biden's campaign fundraisers, where big money mingles with old jokes in swanky homes

iShares U.S. Pharmaceuticals ETF (IHE) Price, Holdings, & News

$178.33
+0.69 (+0.39%)
(As of 12/8/2023 ET)
Compare
Today's Range
$177.13
$178.50
50-Day Range
$166.63
$181.97
52-Week Range
$166.09
$191.74
Volume
18,429 shs
Average Volume
14,161 shs
Market Capitalization
$365.57 million
Assets Under Management
$588.21 million
Dividend Yield
2.09%
Net Expense Ratio
0.39%

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors.

IHE Stock Price History

IHE ETF News Headlines

IHE iShares U.S. Pharmaceuticals ETF
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
The Zacks Analyst Blog Highlights URNJ, IHE and PXE
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Pharma ETF (IHE) Hit a 52-Week High
See More Headlines
Receive IHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
iShares
Fund Name
iShares U.S. Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:IHE
Inception Date
5/1/2006
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Dow Jones U.S. Select Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
38

Fund Statistics

Assets Under Management
$588.21 million
Average Daily Volume
$14,094.10
Discount/Premium
0.08%

Administrator, Advisor and Custodian

Administrator
Citibank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
Citibank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
Citibank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
N/A
Short Interest
33,700 shs

Miscellaneous

Beta
0.70
Creation Unit
50,000
Creation Fee
$306.00
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

iShares U.S. Pharmaceuticals ETF Expenses

TypeIHEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.39%0.56%0.53%0.50%0.51%
Other Expenses0.00%0.40%0.54%0.64%0.57%
Total Expense0.39%0.72%0.70%0.73%0.70%
Fee Waiver0.00%-0.51%-0.54%-0.69%-0.57%
Net Expense0.39%0.61%0.60%0.57%0.57%

iShares U.S. Pharmaceuticals ETF (IHE) Holdings & Exposure

Key Executives

  • George G. C. Parker Ph.D. (Age 78)
    Independent Chairman of the Board of Trustees
  • Michael Arthur Latham (Age 51)
    President, Trustee
  • Jack Gee (Age 57)
    Chief Financial Officer, Treasurer
  • Geoffrey D. Flynn
    Chief Operating Officer, Executive Vice President
  • Amy Schioldager (Age 56)
    Executive Vice President
  • Ira P. Shapiro (Age 52)
    Vice President, Chief Legal Officer
  • Matt Tucker
    Vice President
  • Eilleen M. Clavere (Age 61)
    Secretary
  • Cecilia H. Herbert (Age 68)
    Independent Trustee
  • Charles A. Hurty (Age 73)
    Independent Trustee














IHE ETF - Frequently Asked Questions

How have IHE shares performed in 2023?

iShares U.S. Pharmaceuticals ETF's stock was trading at $186.13 on January 1st, 2023. Since then, IHE stock has decreased by 4.2% and is now trading at $178.3259.
View the best growth stocks for 2023 here
.

What does IHE invest in?

iShares U.S. Pharmaceuticals ETF is a equity fund issued by iShares. IHE focuses on health care investments and follows the Dow Jones U.S. Select Pharmaceuticals Index. The fund's investments total to approximately $588.21 million assets under management.

What stocks does iShares U.S. Pharmaceuticals ETF hold?
What is the management fee for iShares U.S. Pharmaceuticals ETF?

iShares U.S. Pharmaceuticals ETF's management fee is 0.39% and has no other recorded expenses or fee waivers. The net expense ratio for IHE is 0.39%.

What other stocks do shareholders of iShares U.S. Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares U.S. Pharmaceuticals ETF investors own include United Parcel Service (UPS), CVS Health (CVS), Genuine Parts (GPC), Intel (INTC), Kinder Morgan (KMI), Wells Fargo & Company (WFC), Archer-Daniels-Midland (ADM), BP (BP) and Campbell Soup (CPB).

Who are iShares U.S. Pharmaceuticals ETF's major shareholders?

iShares U.S. Pharmaceuticals ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include Envestnet Asset Management Inc. (3.12%), Raymond James & Associates (2.78%), Royal Bank of Canada (1.81%), RiverFront Investment Group LLC (1.76%), LPL Financial LLC (1.18%) and UBS Group AG (0.72%).

How do I buy shares of iShares U.S. Pharmaceuticals ETF?

Shares of IHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSEARCA:IHE) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -